Thomas C. Quinn

Q: What Schools Are Affiliated With Thomas C. Quinn

Thomas C. Quinn is affiliated with the following schools: Makerere University, University of Louisville, Johns Hopkins University, University of Washington, University of California, San Francisco, Cayetano Heredia University

Thomas C. Quinn's AcademicInfluence.com Rankings

Thomas C. Quinn

Philosophy

#7730

World Rank

#10981

Historical Rank

Logic

#4769

World Rank

#6098

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Thomas C. Quinn's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Thomas C. Quinn Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Thomas C. Quinn is an American physician and infectious disease researcher specializing in the study of HIV/AIDS. He is a professor of medicine and pathology at the Johns Hopkins School of Medicine and director of the Johns Hopkins Center for Global Health. He is also a professor of international health, epidemiology, and molecular microbiology and immunology at the Johns Hopkins School of Public Health and a professor of nursing the Johns Hopkins School of Nursing. In addition, he serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases.

(See a Problem?)

Thomas C. Quinn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Laboratory medicine in Africa: a barrier to effective health care. (2006) (681)
Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells (1996) (507)
Better Tests, Better Care: Improved Diagnostics for Infectious Diseases (2013) (492)
AIDS in Africa: an epidemiologic paradigm (1986) (408)
Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. (2003) (300)
Incident Chlamydia trachomatis infections among inner-city adolescent females. (1998) (300)
Azithromycin in control of trachoma (1999) (300)
Multicenter Evaluation of the BDProbeTec ET System for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Specimens, Female Endocervical Swabs, and Male Urethral Swabs (2001) (293)
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda (2007) (283)
The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. (1998) (278)
Chlamydia trachomatis infections in female military recruits. (1998) (277)
Hematologic abnormalities in the acquired immune deficiency syndrome. (1984) (267)
Prevalence of enteric pathogens in homosexual men with and without acquired immunodeficiency syndrome. (1988) (263)
The polymicrobial origin of intestinal infections in homosexual men. (1983) (258)
Multiply antibiotic-resistant Staphylococcus aureus: introduction, transmission, and evolution of nosocomial infection. (1982) (249)
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. (1996) (242)
Performance of the APTIMA Combo 2 Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Female Urine and Endocervical Swab Specimens (2003) (228)
Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay (1993) (222)
Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. (1996) (211)
Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene (1992) (208)
Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix (1994) (204)
Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. (1995) (198)
Characterization of Campylobacter-like organisms isolated from homosexual men. (1984) (189)
Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features. (1983) (186)
Gastrointestinal Infections in AIDS (1992) (183)
Vaginal Swabs Are Appropriate Specimens for Diagnosis of Genital Tract Infection with Chlamydia trachomatis (2003) (176)
Touchdown Enzyme Time Release-PCR for Detection and Identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci Using the 16S and 16S-23S Spacer rRNA Genes (2000) (175)
Diagnosis of Trichomonas vaginalis Infection by PCR Using Vaginal Swab Samples (1999) (173)
HIV epidemiology and the effects of antiviral therapy on long-term consequences (2008) (173)
Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. (1995) (171)
Diagnosis of Chlamydia trachomatis urethral infection in symptomatic and asymptomatic men by testing first-void urine in a ligase chain reaction assay. (1994) (170)
Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens (2004) (169)
The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Selected Populations in Five Countries (2011) (166)
Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients (1994) (155)
Multicenter Evaluation of AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for Neisseria gonorrhoeae (2000) (149)
Multicenter Evaluation of the AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for Detection ofChlamydia trachomatis (2000) (146)
Screening Women for Chlamydia trachomatis in Family Planning Clinics: The Cost‐Effectiveness of DNA Amplification Assays (1998) (139)
Role of the mononuclear phagocyte system in the immunopathogenesis of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. (1988) (139)
Mycoplasma genitalium as a Contributor to the Multiple Etiologies of Cervicitis in Women Attending Sexually Transmitted Disease Clinics (2009) (133)
Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha (1995) (130)
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. (1984) (130)
Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. (1998) (127)
Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates. (1988) (123)
Acute primary HIV infection. (1997) (122)
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. (1995) (120)
Community‐Acquired Pneumonia: Impact of Immune Status (1996) (119)
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay (1990) (119)
Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics (1996) (117)
Radical changes to chlamydial taxonomy are not necessary just yet. (2001) (117)
Atherosclerosis in apoE knockout mice infected with multiple pathogens. (2001) (109)
Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay (1997) (106)
Intestinal spirochetosis in homosexual men. (1987) (105)
Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male Army recruits. (2001) (104)
Screening for Gonorrhea and Chlamydia by DNA Amplification in Adolescents Attending Middle School Health Centers: Opportunity for Early Intervention (1998) (103)
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay (1991) (101)
Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening. (1994) (94)
Unsuspected Gonorrhea and Chlamydia in Patients of an Urban Adult Emergency Department: A Critical Population for STD Control Intervention (2001) (93)
The etiology of anorectal infections in homosexual men. (1981) (93)
Molecular Diagnosis of Chlamydia pneumoniae Infection (1999) (93)
Pooling Urine Samples for Ligase Chain Reaction Screening for Genital Chlamydia trachomatis Infection in Asymptomatic Women (1998) (93)
Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. (2008) (92)
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients. (2003) (88)
Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females (2001) (87)
Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification. (1990) (86)
Presence of Chlamydia pneumoniae in Human Symptomatic and Asymptomatic Carotid Atherosclerotic Plaque (2001) (85)
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team. (1998) (83)
Diagnosis of Chlamydia trachomatis infections by direct immunofluorescence staining of genital secretions. A multicenter trial. (1984) (83)
Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. (2001) (82)
Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia Trachomatis Assay (AMP CT) in Urine Specimens from Men and Women and Endocervical Specimens from Women (1998) (82)
Demonstration of chlamydial RNA and DNA during a culture-negative state (1992) (79)
Severe disease in children with trachoma is associated with persistent Chlamydia trachomatis infection. (1997) (79)
Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population. (1993) (76)
Pathologic features of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. (1987) (75)
Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics (2009) (72)
Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. (1989) (72)
Acquired immune deficiency syndrome and pancytopenia. (1983) (72)
Diagnosis of Trichomonas vaginalisInfection by PCR Using Vaginal Swab Samples (1998) (71)
Prevalence of chlamydial and gonococcal infections among young adults. (2004) (70)
Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma (1996) (70)
Use of Multiple Nucleic Acid Amplification Tests To Define the Infected-Patient “Gold Standard” in Clinical Trials of New Diagnostic Tests for Chlamydia trachomatis Infections (2004) (70)
Sustained High Prevalence of Chlamydia trachomatis Infections in Female Army Recruits (2003) (70)
Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay. (1994) (69)
Preference Among Female Army Recruits for Use of Self-Administrated Vaginal Swabs or Urine to Screen for Chlamydia trachomatis Genital Infections (2003) (68)
Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. (2001) (68)
In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. (1999) (67)
The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. (1995) (66)
Evaluation of Dry and Wet Transported Intravaginal Swabs in Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Female Soldiers by PCR (2002) (66)
The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA®Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The Infected Patient Standard Reduces Sensitivity of Single Site Evaluation (2004) (65)
Use of Ligase Chain Reaction with Urine versus Cervical Culture for Detection of Chlamydia trachomatis in an Asymptomatic Military Population of Pregnant and Nonpregnant Females Attending Papanicolaou Smear Clinics (1998) (63)
Performance of the Gen-Probe Transmission-Mediated Amplification Research Assay Compared to That of a Multitarget Real-Time PCR for Mycoplasma genitalium Detection (2006) (62)
Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia (2013) (61)
Control of Chlamydia trachomatis infections in female army recruits: cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. (1999) (61)
Chlamydia pneumoniae in acute otitis media. (1997) (60)
Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance. (2002) (60)
Cost-Effectiveness of Screening Strategies for Chlamydia trachomatis Using Cervical Swabs, Urine, and Self-Obtained Vaginal Swabs in a Sexually Transmitted Disease Clinic Setting (2008) (58)
Defective reticuloendothelial system Fc-receptor function in patients with acquired immunodeficiency syndrome. (1985) (58)
Chlamydia trachomatis Reinfection Rates Among Female Adolescents Seeking Rescreening in School-Based Health Centers (2008) (58)
Enhancing the Specificity of the COBAS AMPLICOR CT/NG Test forNeisseria gonorrhoeae by Retesting Specimens with Equivocal Results (2001) (57)
Cost-Effectiveness Analysis of Screening Adolescent Males for Chlamydia On Admission to Detention (2004) (57)
Intravascular clearance of parasitized erythrocytes in rodent malaria. (1979) (55)
Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. (2002) (52)
Relationship of alterations in splenic clearance function and microcirculation to host defense in acute rodent malaria. (1981) (51)
Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. (1986) (51)
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae (1992) (50)
Detection of Chlamydia trachomatis in tissue culture and cervical scrapings by in situ DNA hybridization. (1986) (50)
Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. (1993) (50)
Spectrum of rectal biopsy abnormalities in homosexual men with intestinal symptoms. (1986) (49)
Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania (2011) (49)
Studies on phagocytosis in patients with acute bacterial infections. (1989) (48)
Ability of the Digene Hybrid Capture II Test To Identify Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Specimens (1999) (47)
Erratum: Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples (Journal of Clinical Microbiology (1998) 36:11 (3205- 3210)) (1999) (46)
Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type 1 and 2 in the setting of multiple transmitted viral subtypes (2002) (46)
Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene (1992) (45)
Recent advances in diagnosis of sexually transmitted diseases. (1994) (44)
Comparison of Digene Hybrid Capture 2 and Conventional Culture for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Cervical Specimens (2002) (43)
Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey (2016) (43)
Pooling of Urine Samples for Screening for Neisseria gonorrhoeae by Ligase Chain Reaction: Accuracy and Application (1998) (43)
Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction. (1993) (42)
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis (1987) (41)
Urine nucleic acid amplification tests for the diagnosis of sexually transmitted infections in clinical practice (2005) (41)
Performance of the Gen-Probe Transcription-Mediated Amplification Research Assay Compared to That of a Multitarget Real-Time PCR for Mycoplasma genitalium Detection (2006) (40)
Postabortal Endometritis and Isolation of Chlamydia trachomatis (1986) (40)
Screening for Chlamydia trachomatis infection in an inner-city population: a comparison of diagnostic methods. (1985) (40)
Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control? (2014) (39)
Rectal mass caused by Treponema pallidum: confirmation by immunofluorescent staining. (1982) (38)
Experimental infection with Chlamydia pneumoniae in nonhuman primates (1990) (37)
Use of nucleic acid probes for the detection of sexually transmitted infectious agents. (1986) (37)
Adolescent Chlamydia Testing Practices and Diagnosed Infections in a Large Managed Care Organization (2001) (36)
Provider willingness to screen all sexually active adolescents for chlamydia (2002) (36)
Real-time PCR for Chlamydia pneumoniae utilizing the Roche Lightcycler and a 16S rRNA gene target. (2004) (36)
Evaluation of Syva enzyme immunoassay for detection of Chlamydia trachomatis in genital specimens (1990) (35)
Demonstration of defective C3-receptor-mediated clearance by the reticuloendothelial system in patients with acquired immunodeficiency syndrome. (1987) (35)
Evaluation of the Digene Hybrid Capture II CT-ID Test for Detection of Chlamydia trachomatis in Endocervical Specimens (1999) (35)
A Comparison of Two Measures of HIV Diversity in Multi-Assay Algorithms for HIV Incidence Estimation (2014) (35)
Comparison of the Abbott m2000 RealTime CT Assay and the Cepheid GeneXpert CT/NG Assay to the Roche Amplicor CT Assay for Detection of Chlamydia trachomatis in Ocular Samples from Tanzania (2013) (34)
Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences. (1993) (34)
Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. (1987) (34)
Genetic diversification and recombination of HIV type 1 group M in Kinshasa, Democratic Republic of Congo. (2005) (33)
The challenge of sexually transmitted diseases for the military: what has changed? (2000) (33)
Thrombophlebitis and Cellulitis Due to Campylobacter fetus ssp. fetus: REPORT OF FOUR CASES AND A REVIEW OF THE LITERATURE (1985) (33)
Gene Typing of Chlamydia trachomatis by Polymerase Chain Reaction and Restriction Endonuclease Digestion (1992) (33)
The Johns Hopkins Center for Global Health: transcending borders for world health. (2008) (33)
Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men (1994) (32)
Resolution of acute malaria (Plasmodium berghei in the rat): reversibility and spleen dependence. (1980) (31)
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae (1996) (31)
The epidemiology of the acquired immunodeficiency syndrome in the 1990s. (1995) (31)
Screening cornea donors for antibodies against human immunodeficiency virus. Efficacy of ELISA testing of cadaveric sera and aqueous humor. (1987) (30)
Influence of endocervical specimen adequacy on PCR and direct fluorescent-antibody staining for detection of Chlamydia trachomatis infections (1997) (30)
Hospitalization Rates in Female US Army Recruits Associated With a Screening Program for Chlamydia trachomatis (2002) (29)
New developments in serologic screening of corneal donors for HIV-1 and hepatitis B virus infections. (1992) (29)
Experimental proctitis due to rectal infection with Chlamydia trachomatis in nonhuman primates. (1986) (29)
Point-of-entry screening for C. trachomatis In female army recruits. Who derives the cost savings? (2000) (29)
Evaluation of Vaginal Infections in Adolescent Women: Can It Be Done Without a Speculum? (1998) (28)
Mechanisms of action of hyperimmune serum in mediating protective immunity to rodent malaria (Plasmodium berghei). (1979) (28)
Urine as a Diagnostic Specimen for the Detection of Chlamydia trachomatis in Malaysia by Ligase Chain Reaction (1996) (27)
Correlation of chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation1 (2002) (27)
Campylobacter proctitis in a homosexual man. (1980) (26)
A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma (2013) (26)
Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays. (2002) (26)
Rapid diagnosis of Chlamydia psittaci pneumonia. (1993) (26)
Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results. (2013) (25)
Epidemiology of neonatal conjunctivitis. (1986) (24)
The impact of antimicrobial resistance on the treatment of sexually transmitted diseases. (1997) (24)
The role of Chlamydia pneumoniae in cardiovascular disease. (2000) (24)
Field Evaluation of the Cepheid GeneXpert Chlamydia trachomatis Assay for Detection of Infection in a Trachoma Endemic Community in Tanzania (2013) (24)
Case Report: Kaposi’s Sarcoma with Bone Marrow Involvement: Occurrence in a Patient with the Acquired Immunodeficiency Syndrome (1986) (24)
Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay. (2015) (23)
Use of Lambda Phage DNA as a Hybrid Internal Control in a PCR-Enzyme Immunoassay To Detect Chlamydia pneumoniae (1998) (23)
NIH conference. Gastrointestinal infections in AIDS. (1992) (23)
The impact of the AIDS epidemic on corneal transplantation. (1985) (22)
Impaired antibody-dependent cell-mediated cytotoxic activity in patients with the acquired immunodeficiency syndrome. (1986) (22)
The academic alliance for AIDS care and prevention in Africa. (2001) (21)
Update on male circumcision: Prevention success and challenges ahead (2008) (21)
Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? (2011) (21)
Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearance (1987) (20)
Risk Factors for Ocular Infection with Chlamydia trachomatis in Children 6 Months following Mass Treatment in Tanzania (2011) (20)
Should Asymptomatic Men Be Included in Chlamydia Screening Programs? Cost-Effectiveness of Chlamydia Screening Among Male and Female Entrants to a National Job Training Program (2008) (20)
HIV infection and AIDS in children. (1992) (19)
Recovery of Campylobacter species from homosexual men. (1988) (19)
The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Follicular Trachoma in Preschool-Aged Children (2014) (19)
Screening for HIV infection--benefits and costs. (1992) (19)
Performance of urine leukocyte esterase in asymptomatic male youth: another look with nucleic acid amplification testing as the gold standard for Chlamydia detection. (2005) (19)
The Spermicide Nonoxynol‐9 Does Not Inhibit Chlamydia trachomatis in Vitro (1986) (19)
Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data (2010) (18)
Detection of Chlamydia trachomatis cervical infection: a comparison of Papanicolaou and immunofluorescent staining with cell culture. (1987) (18)
Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. (2013) (17)
Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area (2018) (17)
Multicenter evaluation of the AntigEnz Chlamydia enzyme immunoassay for diagnosis of Chlamydia trachomatis genital infection (1992) (17)
A systematic approach to the diagnosis and treatment of chronic conjunctivitis. (1990) (16)
Attitudes and Decision Making About Neonatal Male Circumcision in a Hispanic Population in New York City (2012) (16)
Estimating the rate of occurrence of new HIV infections using serial prevalence surveys: the epidemic in India. (1996) (16)
Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control (2015) (16)
Diagnosis of Chlamydia trachomatis in biopsied tissue specimens by using in situ DNA hybridization. (1988) (16)
The AIDS Epidemic in India: A New Method for Estimating Current HIV Incidence Rates (1995) (15)
DNA amplification assays: a new standard for diagnosis of Chlamydia trachomatis infections. (1995) (15)
Human leukocyte antigen (HLA)-B, DRB1, and DQB1 allotypes associated with disease and protection of trachoma endemic villagers. (2009) (15)
Clinical Reactivations of Herpes Simplex Virus Type 2 Infection and Human Immunodeficiency Virus Disease Progression Markers (2010) (15)
Disease Prevalence Among Women Attending a Sexually Transmitted Disease Clinic Varies with Reason for Visit (1992) (15)
Does Chlamydia pneumoniae cause coronary heart disease? (1998) (15)
Performance of the MagNA Pure LC Robot for Extraction of Chlamydia trachomatis and Neisseria gonorrhoeae DNA from Urine and Swab Specimens (2004) (15)
Chlamydia, Gonorrhea, and HIV-1 Prevalence Among Five Populations of Women in the Czech and Slovak Republics (2001) (14)
Geospatial distribution and clustering of Chlamydia trachomatis in communities undergoing mass azithromycin treatment. (2014) (14)
Evaluation of Abbott Testpack® Chlamydia for Detection of Chlamydia trachomatis in Patients Attending Sexually Transmitted Diseases Clinics (1990) (14)
Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study. (2002) (14)
Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates (1987) (13)
Clinical approach to intestinal infections in homosexual men. (1986) (13)
Cohort and age effects of mass drug administration on prevalence of trachoma: a longitudinal study in rural Tanzania. (2014) (13)
Viral load, circumcision and heterosexual transmission. (2000) (13)
Mission now possible for AIDS fund (2001) (12)
Gay bowel syndrome. The broadened spectrum of nongenital infection. (1984) (12)
Do infants increase the risk of re-emergent infection in households after mass drug administration for trachoma? (2011) (12)
Stability of Chlamydia trachomatis on Storage of Dry Swabs for Accurate Detection by Nucleic Acid Amplification Tests (2014) (12)
Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity (2013) (12)
Cytopathologic detection of chlamydia trachomatis in vaginopancervical (fast) smears (1988) (12)
Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation (ASANTE) Trial: Design and Baseline Characteristics (2016) (11)
Treatment for Chlamydia Infection--Doxycycline versus Azithromycin. (2015) (11)
Crohn's disease (1987) (10)
Epidemiologic approaches to global health. (2010) (9)
Screening of Chlamydia trachomatis urogenital infections among the male and female population of the Republic of Macedonia (2005) (9)
Cellular immune status in retinitis pigmentosa. (1988) (9)
African trypanosomiasis in an American hunter in East Africa. (1983) (8)
Urogenital Chlamydia trachomatis multilocus sequence types and genovar distribution in chlamydia infected patients in a multi-ethnic region of Saratov, Russia (2018) (8)
Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses. (1984) (8)
AIDS in the Americas. (1990) (8)
Diagnosis ofChlamydia trachomatis Cervical Infection byDetection ofAmplified DNA withanEnzymeImmunoassay (1990) (8)
Estimation of Current HIV Incidence Rates from a Cross-Sectional Survey Using Early Diagnostic Tests (1995) (8)
Epidemiologic trends in HIV infection (1992) (7)
Human Retroviral Infections in the Tropics (2006) (7)
Pre-erythrocytic rodent malaria, Plasmodium berghei--prevention of development in the ethionine fatty liver. (1972) (7)
Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women (2018) (7)
CD4 Stabilization Tubes Provide Improved Accuracy of Absolute CD4 T-Cell Counts Compared to Standard K3 EDTA Tubes in Human Immunodeficiency Virus Immunologic Monitoring in Resource-Poor Settings (2008) (7)
Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017 (2018) (6)
World AIDS Day: reflections on the pandemic. (2003) (6)
The global HIV/AIDS pandemic 2002: a status report. (2002) (6)
Oral administration of cyclosporin does not prevent expansion of antigen-specific, gut-associated, and spleen lymphocyte populations duringChlamydia trachomatis proctitis in nonhuman primates (1989) (6)
The Microbicide Tenofovir Does Not Inhibit Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples (2007) (6)
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay (1991) (6)
More on routine HIV screening. (1993) (6)
Chlamydia pneumoniae and multiple sclerosis: Innocent bystander or culprit? (2001) (5)
DETECTION AND DIFFERENTIATION OF CHLAIRANIAN MYDIA TRACHOMATIS, CHLAMYDIA PSITTACI, CHLAMYDIA PNEUMONIAE BY DNA AMPLICATION (1990) (5)
Success hinges on support for treatment (2001) (5)
Measuring Trachomatous Inflammation-Intense (TI) When Prevalence Is Low Provides Data on Infection With Chlamydia trachomatis (2017) (5)
Addressing Future Epidemics: Historical Human Rights Lessons from the AIDS Pandemic (2016) (5)
The effect of Mass Drug Administration for trachoma on antibodies to Chlamydia trachomatis pgp3 in children (2020) (5)
Decline in rates of clearance of IgG-sensitized erythrocytes with increasing age. (1988) (5)
The global HIV pandemic: lessons from the past and glimpses into the future. (2001) (5)
The resurgence of malaria. Diagnostic and therapeutic dilemmas. (1981) (5)
Interferon Induction by Polymers (1985) (5)
The Utility of a Composite Biological Endpoint in HIV/STI Prevention Trials (2013) (5)
Treating village newcomers and travelers for trachoma: Results from ASANTE cluster randomized trial (2017) (4)
Kaposi's sarcoma with bone marrow involvement: occurrence in a patient with the acquired immunodeficiency syndrome. (1986) (4)
Global infectious diseases and urbanization. (2010) (4)
The clinical utility of viral load monitoring in HIV infection: strengths and limitations. (1996) (4)
The International Epidemiology of HIV-1 Infections (1991) (4)
Perspectives on the AIDS epidemic: the experience within the United States. (1989) (4)
New developments in infectious diarrhea. (1986) (4)
Acceptability and feasibility of recruiting women to collect a self-administered vaginal swab at a pharmacy clinic for sexually transmissible infection screening. (2020) (3)
Failure to detect Chlamydia trachomatis in cell culture by using a monoclonal antibody directed against the major outer membrane protein (1997) (3)
HTLV-III ELISA testing of cadaveric sera to screen potential organ transplant donors. (1986) (3)
Precautions for Patients Hospitalized with Acquired Immunodeficiency Syndrome (1983) (3)
Cost-Effectiveness of Chlamydial Screening (1998) (3)
The Global Epidemiology of AIDS (2004) (3)
Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity (2013) (3)
Entry inhibitors: a primer on the class and on its most promising agents. (2004) (3)
Genetic Polymorphisms of TLR4 and MICA are Associated with Severity of Trachoma Disease in Tanzania (2016) (3)
Urethritis treatment : Sexually transmitted diseases (1998) (3)
Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: Interleukin-1 and interleukin-2 modifyin vitro responses (1984) (3)
Medical response to AIDS epidemics. (1984) (3)
John G. Bartlett: a transformative, visionary leader of Johns Hopkins Infectious Diseases. (2014) (2)
Current topics in AIDS. Volume 1. (1987) (2)
Neisseria gonorrhoeae : Detection and Typing by Probe Hybridization, LCR, and PCR. (1999) (2)
Homosexual men with thrombocytopenia have impaired reticuloendothelial system Fc receptor-specific clearance. (1987) (2)
Personal Religiosity and Mental Health Care Utilization among Adolescents (2015) (2)
Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania (2019) (2)
MODULATION OF VIRUS‐SPECIFIC IMMUNITY IN VITRO BY THE ADDITION OF INTERLEUKIN‐1 AND INTERLEUKIN‐2 IN PATIENTS WITH THE ACQUIRED IMMUNE DEFICIENCY SYNDROME a (1984) (2)
Epidemiology of HIV infections: international and U.S. perspectives. (1998) (2)
Entamoeba histolytica infections in homosexual men. (1988) (2)
Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia (2013) (1)
Urethritis treatment. (1998) (1)
High prevalence of Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT) documented in middle school students by urine based DNA screening (1998) (1)
Response to the global AIDS pandemic: the global AIDS fund--will it be enough and will it succeed? (2001) (1)
Characterization of lymphocytes having NK function in intestinal lamina propria of normal and lymphogranuloma venereum (LOV)-infected non-human primates (1985) (1)
Screening for HIV infection in sexually transmitted disease clinics. (1988) (1)
The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Active Trachoma (2012) (1)
Sexually transmitted enteric infections (2021) (1)
The Effect of Multiple Rounds of Mass Drug Administration on the Association between Ocular Chlamydia trachomatis Infection and Active Trachoma (2012) (1)
Can nucleic acid amplification tests be used to test for chlamydia and gonorrhoea in microbicide trials? (2007) (1)
Epidemiologic and Serologic Evidence for a Role of Herpesviruses in HIV Infection (1990) (1)
The Effect on Trachoma and ocular C. trachomatis in Villages of Multiple, Yearly, Mass Antibiotic Treatment in Tanzania: Charting the Course for the Tanzania National Trachoma Control Program (2008) (1)
Update on Chlamydia trachomatis infections (1994) (1)
Predictors of Chlamydia trachomatis (CT) infection diagnosed by polymerase chain reaction (PCR) among adolescent females with repeat visits to inner city clinics (1998) (1)
Viral STDs: herpes simplex and human papillomavirus. (1987) (1)
The restless tide: the HIV pandemic. (1999) (1)
Erratum: Radical changes to chlamydial taxonomy are not necessary just yet (International Journal of Systematic and Evolutionary Microbiology (2006) vol. 51 (249)) (2006) (1)
The epidemiology of AIDS: a decade of experience. (1991) (1)
Identification ofChlamydia pneumoniae byDNA Amplification ofthe16SrRNAGene (1992) (1)
Azithromycin in control of trachoma. (1999) (1)
P480 Enhanced prevalence of Chlamydia trachomatis DNA in clinical samples of patients with STIs co-infection (2019) (0)
Viral Load and Transmission in Uganda (2001) (0)
PANDEMIC INFLUENZA: A CALL TO ACTION* (2007) (0)
Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area (2018) (0)
Chlamydia Pneumoniae and Giant-Cell Arteritis: Failure to Detect Chlamydia Pneumoniae in Temporal Artery Biopsies by Polymerase Chain Reaction in 90 Cases and 90 Controls (2002) (0)
Chlamydia Trachomatis Infection Among Incoming Families to Communities with Annual Mass Treatment Distribution of Anbiotics for Trachoma Control, PRET Study (2012) (0)
H-104 The HIV pandemic in Sub-Saharan Africa: Challenges, successes and leadership (2018) (0)
Demonstration of Defective C 3-Receptor-mediated Clearance by the Reticuloendothelial System in Patients with Acquired Immunodeficiency Syndrome (2013) (0)
DNA amplification of the 16S rRNA gene. Identification of Chlamydia pneumoniae by (2013) (0)
John Chandler Hume, MD, DrPH (1999) (0)
Diagnosis of Trichomonas vaginalis infection by polymerase chain reaction (PCR) (1997) (0)
Ligase Chain Reaction for Detecting Sexually Transmitted Diseases (2002) (0)
Journal of Infectious Disease: Preface (2000) (0)
A z i t h r o mycin in control of trachoma (1999) (0)
Religion, social capital, and health among recent immigrants to the United States (2015) (0)
Atlas of Infectious Diseases (2000) (0)
Acceptability and Feasibility of Recruiting Women To Collect a Self-Administered Vaginal Swab In A Pharmacy Clinic For Screening for Sexually Transmitted Infections (2021) (0)
Evaluation ofanEnzymeImmunoassay forDetection of Chlamydia trachomatis inUrineofAsymptomatic Men (1994) (0)
Crohn's Disease. (2018) (0)
Once Trachoma is gone, what tools can we use for surveillance? (2015) (0)
and T C aortic artery smooth muscle cells . in human macrophages , endothelial cells , and Replication of Chlamydia pneumoniae in vitro (1995) (0)
After Multiple Rounds of Mass Drug Administration for Trachoma, are there only Trachoma families left? (2012) (0)
CHLAMYDIA PNEUMONIAE IN ACUTE OTITIS MEDIA. † 988 (1996) (0)
polymerase chain reaction assay. asymptomatic men by using a rapid urine specimens from symptomatic and Direct detection of Chlamydia trachomatis in (2013) (0)
Risk of seroconversion and seroreversion of antibodies to Chlamydia trachomatis pgp3 in a longitudinal cohort of children in a low trachoma prevalence district in Tanzania (2022) (0)
Epidemiologic and clinical aspects of the acquired immune deficiency syndrome. (1984) (0)
Measuring Severe Inflammatory Trachoma (TI) when prevalence is low provides indirect data on infection with C. trachomatis in endemic communities. (2015) (0)
Author ' s response to reviews Title : Can HIV incidence testing be used for evaluating HIV intervention programs ? (2010) (0)
A Real Chance for Biotechnology (1986) (0)
Book ReviewSmoking: Psychology and pharmacology (1982) (0)
1999 ASTDA Achievement Award Recipient (1999) (0)
Clinical Signs of Trachoma as Indicators of Community Infection with C. Trachomatis (2011) (0)
Replication of Chlamydia pneumoniae in human pulmonary artery endothelial cells (1994) (0)
Contributors (2012) (0)
[Perspectives on the AIDS epidemic: experience in the United States]. (1988) (0)
A Systemic Approach to the Diagnosis of Chronic Conjunctivitis: Reply (1990) (0)
Impact of Repeated Mass Drug Administration on Infection with C. trachomatis in a Longitudinal Cohort of Children in Kongwa, Tanzania (2011) (0)
CHAPTER 81 – Human Retroviral Infections in the Tropics (2011) (0)
Letter to the EditorThe Authors reply (2006) (0)
Economic analysis of Chlamydia screening strategies for male youth entering the job corps (2004) (0)
A tribute to John G. Bartlett, MD (1937-2021). (2021) (0)
Do Infants Increase The Risk Of Re-emergent Infection With C. Trachomatis Post Mass Drug Administration For Trachoma? (2011) (0)

This paper list is powered by the following services:

Other Resources About Thomas C. Quinn

en.wikipedia.org

What Schools Are Affiliated With Thomas C. Quinn?

Thomas C. Quinn is affiliated with the following schools:

Thomas C. Quinn's Academic­Influence.com Rankings